These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

444 related items for PubMed ID: 12745750

  • 1. The effects of intravenous iron treatment on oxidant stress and erythrocyte deformability in hemodialysis patients.
    Cavdar C, Temiz A, Yeniçerioğlu Y, Calişkan S, Celik A, Sifil A, Onvural B, Camsari T.
    Scand J Urol Nephrol; 2003; 37(1):77-82. PubMed ID: 12745750
    [Abstract] [Full Text] [Related]

  • 2. Effect of intravenous iron sucrose on oxidative stress in peritoneal dialysis patients.
    Saglam F, Cavdar C, Uysal S, Cavdar Z, Camsari T.
    Ren Fail; 2007; 29(7):849-54. PubMed ID: 17994454
    [Abstract] [Full Text] [Related]

  • 3. Slow intravenous iron administration does not aggravate oxidative stress and inflammatory biomarkers during hemodialysis: a comparative study between iron sucrose and iron dextran.
    Malindretos P, Sarafidis PA, Rudenco I, Raptis V, Makedou K, Makedou A, Grekas DM.
    Am J Nephrol; 2007; 27(6):572-9. PubMed ID: 17804904
    [Abstract] [Full Text] [Related]

  • 4. Intravenous iron sucrose in Chinese hemodialysis patients with renal anemia.
    Li H, Wang SX.
    Blood Purif; 2008; 26(2):151-6. PubMed ID: 18212498
    [Abstract] [Full Text] [Related]

  • 5. Effect of repeated intravenous iron administration in haemodialysis patients on serum 8-hydroxy-2'-deoxyguanosine levels.
    Maruyama Y, Nakayama M, Yoshimura K, Nakano H, Yamamoto H, Yokoyama K, Lindholm B.
    Nephrol Dial Transplant; 2007 May; 22(5):1407-12. PubMed ID: 17264097
    [Abstract] [Full Text] [Related]

  • 6. Oxidative stress in hemodialysis patients receiving intravenous iron therapy and the role of N-acetylcysteine in preventing oxidative stress.
    Swarnalatha G, Ram R, Neela P, Naidu MU, Dakshina Murty KV.
    Saudi J Kidney Dis Transpl; 2010 Sep; 21(5):852-8. PubMed ID: 20814119
    [Abstract] [Full Text] [Related]

  • 7. The effect of i.v. iron alone or in combination with low-dose erythropoietin in the rapid correction of anemia of chronic renal failure in the predialysis period.
    Silverberg DS, Blum M, Agbaria Z, Deutsch V, Irony M, Schwartz D, Baruch R, Yachnin T, Steinbruch S, Iaina A.
    Clin Nephrol; 2001 Mar; 55(3):212-9. PubMed ID: 11316241
    [Abstract] [Full Text] [Related]

  • 8. Use of ascorbate-rich dialysate to attenuate oxidative stress in maintenance hemodialysis patients.
    Shi XF, Ding F, Zhu QY, Xue J, Lu FM, Gu Y, Lin ST.
    Ren Fail; 2005 Mar; 27(2):213-9. PubMed ID: 15807188
    [Abstract] [Full Text] [Related]

  • 9. Effect of intravenous iron supplementation on hepatic cytochrome P450 3A4 activity in hemodialysis patients: a prospective, open-label study.
    Pai AB, Norenberg J, Boyd A, Raj D, Chan LN.
    Clin Ther; 2007 Dec; 29(12):2699-705. PubMed ID: 18201586
    [Abstract] [Full Text] [Related]

  • 10. Elevated hepatocyte growth factor levels at the beginning of high-flux hemodialysis are due to heparin administration.
    Christidou F, Bamichas G, Galaktidou G, Fragidis S, Gionanlis L, Frangia T, Bischiniotis T, Sombolos K.
    Ren Fail; 2008 Dec; 30(9):861-4. PubMed ID: 18925524
    [Abstract] [Full Text] [Related]

  • 11. [The effect of cocarboxylase treatment on erythrocyte transketolase and blood thiamine in patients with end stage renal disease undergoing maintenance hemodialysis].
    Pietrzak I, Czarnecki R, Baczyk K, Młynarczyk M, Kaczmarek M.
    Przegl Lek; 2000 Dec; 57(7-8):369-73. PubMed ID: 11109306
    [Abstract] [Full Text] [Related]

  • 12. Labile plasma iron generation after intravenous iron is time-dependent and transitory in patients undergoing chronic hemodialysis.
    Rangel EB, Espósito BP, Carneiro FD, Mallet AC, Matos AC, Andreoli MC, Guimarães-Souza NK, Santos BF.
    Ther Apher Dial; 2010 Apr; 14(2):186-92. PubMed ID: 20438541
    [Abstract] [Full Text] [Related]

  • 13. Effect of vitamin E therapy on oxidative stress and erythrocyte osmotic fragility in patients on peritoneal dialysis and hemodialysis.
    Uzum A, Toprak O, Gumustas MK, Ciftci S, Sen S.
    J Nephrol; 2006 Apr; 19(6):739-45. PubMed ID: 17173246
    [Abstract] [Full Text] [Related]

  • 14. Erythrocyte susceptibility to oxidative stress in chronic renal failure patients under different substitutive treatments.
    Lucchi L, Bergamini S, Iannone A, Perrone S, Stipo L, Olmeda F, Caruso F, Tomasi A, Albertazzi A.
    Artif Organs; 2005 Jan; 29(1):67-72. PubMed ID: 15644086
    [Abstract] [Full Text] [Related]

  • 15. Intravenous iron supplementation in children on hemodialysis.
    Leijn E, Monnens LA, Cornelissen EA.
    J Nephrol; 2004 Jan; 17(3):423-6. PubMed ID: 15365964
    [Abstract] [Full Text] [Related]

  • 16. Effect of iron loading on peripheral blood lymphocyte subsets and on circulating cytokine levels in iron-depleted hemodialysis patients receiving erythropoietin.
    Tsouchnikas I, Tsilipakou M, Daniilidis M, Kyriazis G, Pasadakis P, Parapanissiou E, Vargemezis V, Tsakiris D.
    Nephron Clin Pract; 2007 Jan; 107(3):c97-102. PubMed ID: 17890877
    [Abstract] [Full Text] [Related]

  • 17. Effects of hemodialysis, dialyser type and iron infusion on oxidative stress in uremic patients.
    Müller C, Eisenbrand G, Gradinger M, Rath T, Albert FW, Vienken J, Singh R, Farmer PB, Stockis JP, Janzowski C.
    Free Radic Res; 2004 Oct; 38(10):1093-100. PubMed ID: 15512797
    [Abstract] [Full Text] [Related]

  • 18. Acute and subacute effects of EV iron sucrose on endothelial functions in hemodialysis patients.
    Ozkurt S, Ozenc F, Degirmenci NA, Temiz G, Musmul A, Sahin G, Yalcin AU.
    Ren Fail; 2012 Oct; 34(1):1-6. PubMed ID: 22017464
    [Abstract] [Full Text] [Related]

  • 19. Minutes to recovery after a hemodialysis session: a simple health-related quality of life question that is reliable, valid, and sensitive to change.
    Lindsay RM, Heidenheim PA, Nesrallah G, Garg AX, Suri R, Daily Hemodialysis Study Group London Health Sciences Centre.
    Clin J Am Soc Nephrol; 2006 Sep; 1(5):952-9. PubMed ID: 17699312
    [Abstract] [Full Text] [Related]

  • 20. [Effect of oxidative stress in patients with chronic renal failure].
    González Rico M, Puchades MJ, García Ramón R, Saez G, Tormos MC, Miguel A.
    Nefrologia; 2006 Sep; 26(2):218-25. PubMed ID: 16808260
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.